Oryzon Genomics S.A. (ORY.MC)

EUR 2.66

(1.33%)

Net Income Summary of Oryzon Genomics S.A.

  • Oryzon Genomics S.A.'s latest annual net income in 2023 was -3.35 Million EUR , up 20.76% from previous year.
  • Oryzon Genomics S.A.'s latest quarterly net income in 2024 Q3 was -1.37 Million EUR , down -1386.72% from previous quarter.
  • Oryzon Genomics S.A. reported an annual net income of -4.23 Million EUR in 2022, up 9.72% from previous year.
  • Oryzon Genomics S.A. reported an annual net income of -4.68 Million EUR in 2021, down -37.87% from previous year.
  • Oryzon Genomics S.A. reported a quarterly net income of -1.37 Million EUR for 2024 Q3, down -1386.72% from previous quarter.
  • Oryzon Genomics S.A. reported a quarterly net income of -1.14 Million USD for 2024 Q1, up 38.02% from previous quarter.

Annual Net Income Chart of Oryzon Genomics S.A. (2023 - 2019)

Created with Highcharts 11.1.0YearsNet Income20192019.520202020.520212021.520222022.52023-5000000 EUR-4000000 EUR-3000000 EUR-2000000 EUR-1000000 EUR0 EUR

Historical Annual Net Income of Oryzon Genomics S.A. (2023 - 2019)

Year Net Income Net Income Growth
2023 -3.35 Million EUR 20.76%
2022 -4.23 Million EUR 9.72%
2021 -4.68 Million EUR -37.87%
2020 -3.39 Million EUR 0.0%
2019 - EUR 0.0%

Peer Net Income Comparison of Oryzon Genomics S.A.

Name Net Income Net Income Difference
Atrys Health, S.A. -45.59 Million EUR 92.645%
Biotechnologies Assets SA 1.57 Million EUR 313.052%
Pharma Mar, S.A. 1.13 Million EUR 394.894%
Laboratorios Farmaceuticos Rovi, S.A. 170.33 Million EUR 101.968%